1. Home
  2. WILC vs PROF Comparison

WILC vs PROF Comparison

Compare WILC & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WILC
  • PROF
  • Stock Information
  • Founded
  • WILC 1994
  • PROF N/A
  • Country
  • WILC Israel
  • PROF Canada
  • Employees
  • WILC N/A
  • PROF N/A
  • Industry
  • WILC Food Distributors
  • PROF Medical/Dental Instruments
  • Sector
  • WILC Consumer Discretionary
  • PROF Health Care
  • Exchange
  • WILC Nasdaq
  • PROF Nasdaq
  • Market Cap
  • WILC N/A
  • PROF 201.2M
  • IPO Year
  • WILC 1997
  • PROF N/A
  • Fundamental
  • Price
  • WILC $15.21
  • PROF $5.76
  • Analyst Decision
  • WILC
  • PROF Strong Buy
  • Analyst Count
  • WILC 0
  • PROF 1
  • Target Price
  • WILC N/A
  • PROF $12.00
  • AVG Volume (30 Days)
  • WILC 6.5K
  • PROF 66.5K
  • Earning Date
  • WILC 03-11-2025
  • PROF 03-06-2025
  • Dividend Yield
  • WILC 3.98%
  • PROF N/A
  • EPS Growth
  • WILC 122.00
  • PROF N/A
  • EPS
  • WILC 1.39
  • PROF N/A
  • Revenue
  • WILC $158,085,550.00
  • PROF $10,680,000.00
  • Revenue This Year
  • WILC N/A
  • PROF $165.23
  • Revenue Next Year
  • WILC N/A
  • PROF $96.94
  • P/E Ratio
  • WILC $10.93
  • PROF N/A
  • Revenue Growth
  • WILC 5.99
  • PROF 48.35
  • 52 Week Low
  • WILC $8.18
  • PROF $4.75
  • 52 Week High
  • WILC $17.58
  • PROF $11.42
  • Technical
  • Relative Strength Index (RSI)
  • WILC 33.74
  • PROF 28.68
  • Support Level
  • WILC $15.03
  • PROF $4.75
  • Resistance Level
  • WILC $16.30
  • PROF $7.15
  • Average True Range (ATR)
  • WILC 0.63
  • PROF 0.50
  • MACD
  • WILC -0.14
  • PROF -0.11
  • Stochastic Oscillator
  • WILC 7.14
  • PROF 43.92

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: